State Street Corp Agios Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,951,113 shares of AGIO stock, worth $71.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,951,113
Previous 2,449,479
20.35%
Holding current value
$71.8 Million
Previous $71.8 Million
9.58%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$212 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$209 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$179 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$132 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$85.6 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.02B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...